Cerevance

company

About

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$21.50M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle the early onset of various neurological diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$26.50M
Cerevance has raised a total of $26.50M in funding over 2 rounds. Their latest funding was raised on Feb 21, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 21, 2018 Series Unknown 1 Detail
May 3, 2017 Series A $5M 1 Detail
Dec 2, 2016 Series A $21.50M 1 Takeda Detail

Investments

Number of Investments
Number of Lead Investments
3
0
Cerevance has made 3 investments. Their most recent investment was on Oct 28, 2018, when StarkWare Industries raised $30M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $30M Blockchain
Nov 13, 2017 Wellthy
Seed $4.59M Health Care
Aug 21, 2017 BillionToOne
Seed Biotechnology

Investors

Number of Lead Investors
Number of Investors
1
1
Cerevance is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Series Unknown